Visilizumab | m-entrepreneurship.com

Product Name :
Visilizumab

Search keywords :
Visilizumab

drugId :
null

Target Vo:
T cell surface glycoprotein CD3

Target Vo Short Name :
CD3

Moa_Name:
T cell surface glycoprotein CD3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pdl Biopharma Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Intestinal Neoplasms

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
VEGF Receptor 1 Antibody
IKB alpha Antibody
PDGFR alpha Antibody: PDGFR alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 123 kDa, targeting to PDGFR alpha. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts